A Closer Look at Gilenya - The First Oral Treatment for MS
MSAA's Chief Medical Officer Dr. Jack Burks answers 6 important questions about Gilenya, the new oral medication for MS, including:
- what is Gilenya
- how it differs from current FDA-approved disease modifying therapies?
- side effects
- who might be a candidate to take it
- pregnancy issues
Last Updated on Thursday, 20 November 2014 14:30